![](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/20468268-695918246-abvc-logo-nasdaq-440x386-1-png-100x88.png)
ABVC BioPharma, Inc. Reports Strong Q2 2024 Financial Results and Strategic Achievements
• Executed Global Licensing Agreements that could provide up to $292 million in income • Received Cash Milestone Incomes of $116,000 • Achieved Significant Improvements in Earnings • Obtained Multiple Patents and FDA Approvals FREMONT, CA, Aug. 15, 2024 ( …